BRAF and colorectal carcinoma: Somatic BRAF mutations and loss or reduction of expression of the CDX2 homeobox transcription factor individually and concurrently have been associated with poor prognosis in CRC patients (Bae et al., 2015; Clarke and Kopetz, 2015; Dalerba et al., 2016; Landau et al., 2014).